Oxytocin in diabetic Covid-19 patients: a new perspective

Hayder M. Al-kuraishya Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq

https://orcid.org/0000-0003-3097-2962

Ali I. Al-Gareeba Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq

Omayma A. Eldahshanb Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Cairo, EgyptCorrespondence[email protected]

https://orcid.org/0000-0002-0972-0560

Gaber El-Saber Batihac Department of Pharmacology and Therapeutics, Damanhour University, Damanhour, EgyptCorrespondence[email protected]

References

Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Cruz-Martins N, Batiha GE. 2021a. The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem. 476(11):4161–4166.
PubMed Web of Science ®Google Scholar
Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Guerreiro SG, Cruz-Martins N, Batiha GE. 2021b. COVID-19 in relation to hyperglycemia and diabetes mellitus. Front Cardiovasc Med. 8:644095.
PubMed Web of Science ®Google Scholar
Al-Kuraishy HM, Al-Gareeb AI, Qusty N, Alexiou A, Batiha GE. 2022. Impact of sitagliptin on non-diabetic Covid-19 patients. Curr Mol Pharmacol. 15(4):683–692.
PubMed Web of Science ®Google Scholar
Buemann B, Marazziti D, Uvnäs-Moberg K. 2022. Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients? World J Biol Psychiatry. 22(5):387–398.
Web of Science ®Google Scholar
Diep PT. 2021. Oxytocin may be superior to gliptins as a potential treatment for diabetic COVID-19 patients. SciMed J. 2:106–107.
Google Scholar
Rania RA, Khaled AA. 2018. Effect of oxytocin treatment on asprosin serum level and liver function changes in rats with streptozotocin-induced diabetes. Med J Cairo Univ. 86(12):4417–4428.
Google Scholar
Wang SC, Wang YF. 2021. Cardiovascular protective properties of oxytocin against COVID-19. Life Sci. 270:119130.
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Oxytocin in diabetic Covid-19 patients: a new perspective

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Oxytocin in diabetic Covid-19 patients: a new perspective

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date